Table 2 Demographics and characteristics of the non-diabetic subjects.
From: Investigating the Role of Myeloperoxidase and Angiopoietin-like Protein 6 in Obesity and Diabetes
|  | Non-Obese (n = 77) | Obese (n = 60) | p-value |
|---|---|---|---|
Age | 41.00 (31.00–52.00) | 46.00 (33.75–56.00) | 0.09 |
Gender (Male) | 28 (36.4%) | 24 (40.0%) | 0.79 |
BMI | 24.71 (22.46–26.86) | 34.02 (31.60–36.16) | <0.001 |
Waist/Hip Ratio | 0.84 (0.79–0.89) | 0.90 (0.82–0.97) | <0.01 |
TC (mmol/L) | 5.00 (4.35–5.75) | 5.20 (4.60–5.90) | 0.41 |
HDL (mmol/L) | 1.36 (1.09–1.66) | 1.17 (1.01–1.44) | <0.05 |
LDL (mmol/L) | 3.10 (2.50–3.90) | 3.50 (2.80–3.85) | 0.24 |
TGL (mmol/L) | 0.81 (0.60–1.09) | 1.12 (0.66–1.55) | <0.05 |
FPG (mmol/L) | 5.07 (4.80–5.47) | 5.20 (4.90–5.80) | <0.05 |
HbA1c (DCCT %) | 5.50 (5.30–5.80) | 5.70 (5.38–5.93) | 0.08 |
Insulin (mIU/L) | 7.71 (5.21–15.14) | 15.43 (8.10–29.18) | <0.001 |
Adiponectin (μg/mL) | 4.88 (3.21–7.40) | 4.07 (2.45–5.57) | 0.06 |
Leptin (ng/mL) | 5.19 (2.69–7.84) | 10.07 (6.79–13.51) | <0.001 |
PAI-1 (ng/mL) | 13.05 (10.01–16.73) | 15.65 (12.55–19.13) | <0.01 |
IL-6 (pg/mL) | 16.56 (13.19–19.77) | 16.52 (14.17–20.89) | 0.56 |
TNF alpha (pg/mL) | 122.25 (104.67–160.75) | 125.95 (102.36–141.80) | 0.54 |
hsCRP(μg/mL) | 1.06 (0.55–3.04) | 3.07 (1.69–6.53) | <0.001 |
Hypertension | 8 (10.4%) | 8 (13.3%) | 0.79 |
Hyperlipidemia | 6 (7.8%) | 7 (11.7%) | 0.64 |
